
RCEL Valuation
AVITA Medical Inc
- Overview
- Forecast
- Valuation
- Earnings
RCEL Relative Valuation
RCEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RCEL is overvalued; if below, it's undervalued.
Historical Valuation
AVITA Medical Inc (RCEL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.32 is considered Undervalued compared with the five-year average of -5.67. The fair price of AVITA Medical Inc (RCEL) is between 7.19 to 50.11 according to relative valuation methord. Compared to the current price of 5.81 USD , AVITA Medical Inc is Undervalued By 19.22%.
Relative Value
Fair Zone
7.19-50.11
Current Price:5.81
19.22%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-30.13
P/B
Median3y
7.55
Median5y
6.36
-33.95
FCF Yield
Median3y
-15.40
Median5y
-11.95
Competitors Valuation Multiple
The average P/S ratio for RCEL's competitors is 1.07, providing a benchmark for relative valuation. AVITA Medical Inc Corp (RCEL) exhibits a P/S ratio of 1.32, which is 23.22% above the industry average. Given its robust revenue growth of 66.73%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

SVRE
Saverone 2014 Ltd
2.790
USD
-1.41%

TVGN
Tevogen Bio Holdings Inc
1.110
USD
-3.48%

ELLO
Ellomay Capital Ltd
17.810
USD
-0.20%

KFS
Kingsway Financial Services Inc
14.430
USD
+2.12%

RDCM
Radcom Ltd
13.855
USD
+0.84%

VUZI
Vuzix Corp
2.340
USD
-2.09%

EP
Empire Petroleum Corp
5.100
USD
+6.03%

LAZR
Luminar Technologies Inc
3.470
USD
+13.77%

ARAY
Accuray Inc
1.360
USD
+1.49%

CHMG
Chemung Financial Corp
52.510
USD
-0.40%
FAQ

Is AVITA Medical Inc (RCEL) currently overvalued or undervalued?
AVITA Medical Inc (RCEL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.32 is considered Undervalued compared with the five-year average of -5.67. The fair price of AVITA Medical Inc (RCEL) is between 7.19 to 50.11 according to relative valuation methord. Compared to the current price of 5.81 USD , AVITA Medical Inc is Undervalued By 19.22% .

What is AVITA Medical Inc (RCEL) fair value?

How does RCEL's valuation metrics compare to the industry average?

What is the current P/B ratio for AVITA Medical Inc (RCEL) as of Jul 23 2025?

What is the current FCF Yield for AVITA Medical Inc (RCEL) as of Jul 23 2025?

What is the current Forward P/E ratio for AVITA Medical Inc (RCEL) as of Jul 23 2025?
